Antibiotic Management for Maggot-Infested Wounds
For maggot-infested wounds, initiate broad-spectrum antibiotics covering polymicrobial flora including gram-positive, gram-negative, and anaerobic organisms, with amoxicillin-clavulanate 875/125 mg twice daily orally or ampicillin-sulbactam 1.5-3.0 g every 6 hours IV as first-line therapy, combined with immediate mechanical removal of maggots and aggressive wound debridement.
Primary Antibiotic Selection
The choice of antibiotics for maggot-infested wounds should follow the same principles as contaminated wound infections, as these wounds harbor complex polymicrobial flora from environmental exposure and tissue necrosis 1, 2:
First-Line Regimens:
- Oral therapy: Amoxicillin-clavulanate 875/125 mg twice daily 1, 2
- IV therapy: Ampicillin-sulbactam 1.5-3.0 g every 6 hours 1, 2
- Alternative IV options: Piperacillin-tazobactam 3.37 g every 6-8 hours or carbapenems (ertapenem, meropenem) 1, 2
For Penicillin-Allergic Patients:
- Fluoroquinolone + metronidazole: Ciprofloxacin 500-750 mg twice daily or levofloxacin 750 mg daily PLUS metronidazole 500 mg every 8 hours 1
- Moxifloxacin monotherapy: 400 mg daily (provides both aerobic and anaerobic coverage) 1
Critical Management Considerations
Immediate Wound Care Priority
Antibiotics alone are insufficient. The maggot-infested wound requires:
- Immediate mechanical removal of all visible maggots
- Aggressive surgical debridement of necrotic tissue
- Copious irrigation to remove larvae and contaminated material
MRSA Coverage Decision
Add anti-MRSA therapy (vancomycin 30 mg/kg/day IV in 2 divided doses, linezolid 600 mg every 12 hours, or daptomycin 4 mg/kg every 24 hours IV) if the patient demonstrates 1:
- Systemic inflammatory response (fever >38°C or <36°C, tachycardia >90 bpm, tachypnea >24/min, WBC >12,000 or <4,000)
- Hypotension or sepsis
- Failed initial antibiotic therapy
- Severe immunocompromise
Tetanus Prophylaxis
Administer tetanus toxoid if >5 years since last dose for contaminated wounds 1. Tdap is preferred over Td if not previously given.
Pathogen-Specific Concerns
Maggot-infested wounds carry unique infectious risks beyond typical wound flora 3, 4, 5:
- Ignatzschineria indica: A rare gram-negative organism associated with myiasis that can cause bacteremia 3
- Wohlfahrtiimonas chitiniclastica: Another maggot-associated pathogen causing bloodstream infections 4
- Polymicrobial flora: Expect Staphylococcus, Streptococcus, Enterococcus, Proteus, Providencia, and anaerobes (Fusobacterium, Prevotella, Porphyromonas) 1, 6
These organisms are typically covered by the broad-spectrum regimens recommended above, but blood cultures should be obtained if systemic infection is suspected.
Duration and Monitoring
- Mild infections: 5-7 days of oral antibiotics after debridement
- Moderate-severe infections: 7-14 days, transitioning from IV to oral based on clinical response
- Monitor for: Spreading cellulitis, systemic signs, wound healing progression
- Obtain wound cultures before starting antibiotics to guide therapy adjustment if initial treatment fails
Important Caveats
Do not confuse uncontrolled myiasis (spontaneous maggot infestation) with therapeutic larval therapy 5. Therapeutic use of sterile Lucilia sericata larvae is a legitimate medical intervention for wound debridement and can be used concurrently with most antibiotics 7. However, spontaneous maggot infestation in neglected wounds represents environmental contamination requiring immediate removal and antimicrobial therapy.
The antimicrobial regimen must provide coverage for environmental organisms, not just typical skin flora, given the contaminated nature of these wounds and the potential for rare maggot-associated pathogens to cause serious bloodstream infections 3, 4.